Analysts: Acorda Therapeutics Inc (ACOR.OQ)

ACOR.OQ on NASDAQ Stock Exchange Global Select Market

37.26USD
1 Aug 2013
Price Change (% chg)

$-0.71 (-1.87%)
Prev Close
$37.97
Open
$37.97
Day's High
$38.40
Day's Low
$36.76
Volume
187,402
Avg. Vol
112,771
52-wk High
$40.87
52-wk Low
$21.34

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.09 December 1 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 4 4
(2) OUTPERFORM 3 3 2 2
(3) HOLD 5 5 5 6
(4) UNDERPERFORM 1 1 1 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.25 2.17

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 11 86.76 91.46 82.00 82.46
Quarter Ending Dec-13 11 90.44 98.00 84.00 88.71
Year Ending Dec-13 11 331.66 345.19 316.00 335.35
Year Ending Dec-14 11 384.70 415.70 363.30 381.35
Earnings (per share)
Quarter Ending Sep-13 10 0.09 0.26 -0.05 0.25
Quarter Ending Dec-13 10 0.09 0.40 -0.08 0.34
Year Ending Dec-13 10 0.24 0.84 -0.16 0.98
Year Ending Dec-14 9 0.91 1.65 0.01 1.33

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 81.05 71.86 9.18 11.33
Quarter Ending Dec-12 78.90 81.47 2.57 3.26
Quarter Ending Sep-12 75.20 77.44 2.24 2.98
Quarter Ending Jun-12 72.55 75.66 3.11 4.29
Quarter Ending Mar-12 70.96 71.25 0.28 0.40
Earnings (per share)
Quarter Ending Mar-13 0.13 -0.03 0.16 122.30
Quarter Ending Dec-12 0.15 0.01 0.14 93.26
Quarter Ending Sep-12 0.10 0.24 0.14 137.86
Quarter Ending Jun-12 0.12 0.11 0.01 7.56
Quarter Ending Mar-12 0.18 0.25 0.07 42.45

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 86.76 86.76 87.03 87.27 82.46
Quarter Ending Dec-13 90.44 90.44 90.62 90.93 88.71
Year Ending Dec-13 331.66 331.66 332.57 333.30 335.35
Year Ending Dec-14 384.70 384.70 384.70 386.68 381.35
Earnings (per share)
Quarter Ending Sep-13 0.09 0.09 0.09 0.11 0.25
Quarter Ending Dec-13 0.09 0.09 0.09 0.11 0.34
Quarter Ending Dec-13 0.24 0.24 0.27 0.31 0.98
Quarter Ending Dec-14 0.91 0.86 0.86 0.97 1.33

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 1 1
Quarter Ending Dec-13 0 0 0 1
Year Ending Dec-13 0 0 0 1
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 1 0 1 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: Stock Traders Daily
$58.00
Provider: Stock Traders Daily
$495.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks